UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

K11_KELAUC

ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — 208 KELA reimbursements: ICD-10 — K51 1 out of 7 registries used, show all original rules.	6942
4. Check minimum number of events None	6942
5. Include endpoints K11_KELAUC1	8429
6. Filter based on genotype QC (FinnGen only)	8429

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF3

NAME	K11_KELAUC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_KELAUC1
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	208
KELA_REIMB_ICD	K51\|556
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8429	4266	4163
Unadjusted period prevalence (%)	1.64	1.45	1.84
Median age at first event (years)	38.04	35.02	41.14

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7552: Matched controls
75522

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

7.8

323.0

5807

22604

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

150.5

323.0

519

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

61.0

323.0

623

111

A07EC02

ATC

mesalazine; oral, rectal

1435.7

323.0

7100

827

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

10.4

323.0

888

952

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

252.5

323.0

950

K50.1

ICD-10 Finland

Crohn disease of large intestine

34.6

323.0

810

261

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

7552

520

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

576.5

323.0

332

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

47.1

323.0

449

101

D94

ICPC

Chronic enteritis/ulcerative colitis

90.9

323.0

571

A07EA02

ATC

hydrocortisone; rectal

215.8

323.0

2769

202

H02AB07

ATC

prednisone; oral

6.2

323.0

2286

4963

K51.8

ICD-10 Finland

Other ulcerative colitis

301.0

323.0

1793

A07EA01

ATC

prednisolone; rectal

193.3

323.0

572

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

850.0

323.0

326

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.1

323.0

3131

11164

J01MA02

ATC

ciprofloxacin; systemic

2.8

323.0

3450

17532

L04AX01

ATC

azathioprine; systemic

49.3

323.0

3030

1013

UJF30

NOMESCO Finland

Ileoscopy through colon

16.2

323.0

3005

2953

K51

ICD-10 Finland

Ulcerative colitis

426.2

323.0

1198

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

300.8

323.0

1276

UJF32

NOMESCO Finland

Coloscopy

17.8

323.0

5370

9190

L01BB02

ATC

mercaptopurine; oral

70.0

323.0

869

140

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

302.6

323.0

4174

307

A07EC01

ATC

sulfasalazine; oral, rectal

9.3

323.0

1897

2638

K50.8

ICD-10 Finland

Other Crohn disease

25.8

323.0

848

368

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

10.5

323.0

1884

2317

K51.5

ICD-10 Finland

Left sided colitis

670.3

323.0

4368

153

A07EA06

ATC

budesonide; oral, local oral

62.9

323.0

2631

636

K50.9

ICD-10 Finland

Crohn disease, unspecified

26.2

323.0

797

339

P01AB01

ATC

metronidazole; oral, rectal

2.6

323.0

3547

18985

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

261.5

323.0

1901

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

162.8

323.0

401

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

734.5

323.0

2843

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

629.2

307.8

303

ZX120

NOMESCO Finland

Intravenous

4.3

286.6

1189

3139

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

345.4

267.4

269

K50.0

ICD-10 Finland

Crohn disease of small intestine

12.2

263.7

498

435

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

122.5

262.3

283

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

531.9

260.6

258

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

252.2

2397

11464

A07EC03

ATC

olsalazine; oral

326.1

247.7

250

K83.0

ICD-10 Finland

Cholangitis

17.5

232.2

375

225

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

10.1

226.3

469

490

L04AB04

ATC

adalimumab; parenteral

8.4

191.8

444

560

4AA12

NOMESCO Finland

46.8

181.0

223

4AB02

NOMESCO Finland

37.8

174.0

224

WX002

NOMESCO Finland

Sedation and analgesia

2.5

171.3

1617

7437

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

169.4

1825

8983

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

25.7

168.4

239

A05AA02

ATC

ursodeoxycholic acid; oral

8.9

166.6

369

431

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

156.8

1731

8573

1370

FHL

Colonoscopy, whole colon

32.6

150.2

200

A02BC02

ATC

pantoprazole; systemic

1.9

148.0

4621

34395

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

140.8

1528

7454

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

10.0

136.1

282

292

A07DA03

ATC

loperamide; oral

5.3

134.7

437

866

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

134.5

2967

19311

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

327.6

128.9

130

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

121.6

818

3028

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

203.1

115.9

120

L04AD01

ATC

ciclosporin; systemic

6.3

114.2

320

529

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.5

113.0

568

1704

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

14.2

110.4

192

138

JFH10

NOMESCO Finland

Total colectomy and ileostomy

52.0

110.3

133

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.7

110.1

517

1467

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

130.9

108.3

116

UJF92

NOMESCO Finland

Capsular endoscopy

5.8

108.1

323

579

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

223.2

106.9

110

JFH11

NOMESCO Finland

Laparoscopic colectomy

352.1

104.4

105

C10AC01

ATC

colestyramine; oral

5.4

102.0

321

612

Z93.2

ICD-10 Finland

Ileostomy status

30.5

100.1

135

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

258.8

99.9

102

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.1

99.8

329

662

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

97.5

870

3776

C05AA08

ATC

fluocortolone; rectal, topical

2.2

95.6

1100

5412

3042

Kela drug reimbursment

129.2

95.2

102

253

Kela drug reimbursment

127.9

94.2

101

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.7

93.9

436

1222

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.5

93.3

469

1402

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

10.7

93.1

185

177

K50

ICD-10 Finland

Crohn disease [regional enteritis]

18.6

88.9

139

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

135.9

88.2

4AA33

NOMESCO Finland

90.3

88.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.6

84.9

409

1180

JFF10

NOMESCO Finland

Loop enterostomy

15.3

83.7

141

3005

Kela drug reimbursment

Tofacitinib

28.0

82.0

113

K92.1

ICD-10 Finland

Melaena

3.5

81.8

412

1232

H02AB09

ATC

hydrocortisone; systemic

4.6

80.0

289

641

5551A

ICD-9 Finland

Regional enteritis, Large intestine

204.6

78.4

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

75.5

828

3955

L04AC05

ATC

ustekinumab; parenteral

18.0

75.4

119

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.2

71.7

233

461

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

28.9

71.2

K51.4

ICD-10 Finland

Inflammatory polyps

151.5

71.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.7

70.8

251

546

3AC01

NOMESCO Finland

7.9

69.8

165

214

6419

FHL

Other measure in this category

49.3

68.5

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

5.5

66.5

206

386

H02AB04

ATC

methylprednisolone; systemic

2.0

66.1

987

5351

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

65.8

257

616

JF1BD

NOMESCO Finland

Very extensive small bowel CT

12.3

65.6

121

100

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

65.6

702

3305

L04AB06

ATC

golimumab; parenteral

7.6

64.9

156

208

5550A

ICD-9 Finland

Regional enteritis, Small intestine

59.0

64.7

N02BE01

ATC

paracetamol; systemic, rectal

1.6

64.0

5958

52716

L04AA29

ATC

tofacitinib; oral

20.7

63.9

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

166.4

63.0

A07AA09

ATC

vancomycin; oral

7.3

62.7

156

219

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

61.5

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.3

59.0

162

261

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.1

59.0

192

381

UJK12

NOMESCO Finland

Peroral cholangioscopy

25.9

58.5

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

21.2

57.8

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

11.5

57.4

109

Z2221

NOMESCO Finland

Medical doctor

1.6

57.3

1897

13109

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

15.2

57.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

56.6

914

5080

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

55.7

2408

17720

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

191.4

55.0

1490

FHL

Sigmoideoscopy (fiberscope)

20.0

54.8

D16

ICPC

Rectal bleeding

4.3

54.0

207

488

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

53.6

216

534

WVA20

NOMESCO Finland

Medicine administration

4.0

52.5

217

549

A02BC01

ATC

omeprazole; systemic

1.6

50.7

1656

11342

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.7

50.7

120

157

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.7

49.3

172

369

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

23.1

49.2

A02BC03

ATC

lansoprazole; oral

1.6

48.5

1739

12169

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.8

48.4

125

186

UJF34

NOMESCO Finland

Left colonoscopy

9.5

47.5

105

L04AA01

ATC

[U] ciclosporin; systemic

5.0

47.2

158

324

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

47.2

886

5167

UJK02

NOMESCO Finland

ERCP

4.1

47.2

193

484

J01MA12

ATC

levofloxacin; systemic

1.7

46.5

1111

6976

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

236.4

46.0

UJG02

NOMESCO Finland

Proctoscopy

3.8

45.3

198

527

TJF80

NOMESCO Finland

Ostomy education

6.8

45.1

116

172

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

44.5

815

4709

L04AA33

ATC

vedolizumab; parenteral

64.1

44.1

N02AX02

ATC

tramadol; systemic, rectal

1.4

44.1

2606

20217

A02BC05

ATC

esomeprazole; systemic

1.4

43.7

2486

19138

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

8.1

42.6

123

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

42.2

1353

9167

ZXE00

NOMESCO Finland

One hour or less

1.4

42.1

2574

20050

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

15.8

42.1

R50.9

ICD-10 Finland

Fever, unspecified

1.7

41.8

905

5505

B01AB05

ATC

enoxaparin; parenteral

1.5

41.8

1702

12191

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

113.2

41.7

JHA00

NOMESCO Finland

Anal or perianal incision

4.3

41.7

161

383

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

41.5

627

3383

D06BX01

ATC

metronidazole; topical

1.9

41.3

656

3605

K60.3

ICD-10 Finland

Anal fistula

3.6

41.1

190

531

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

40.8

441

2073

UJF02

NOMESCO Finland

Peroral enteroscopy

8.2

40.1

112

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

39.7

1713

12409

JFF13

NOMESCO Finland

Terminal enterostomy

19.5

39.5

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

38.2

480

2407

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

37.6

2467

19363

6410

FHL

Panprococolectomy and ileostomy

+∞

37.5

D11

ICPC

Diarrhoea

1.7

37.5

789

4751

M45

ICD-10 Finland

Ankylosing spondylitis

3.2

36.9

204

655

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

190.9

36.8

D18

ICPC

Change in faeces/bowel movements

3.5

36.0

173

500

K56.7

ICD-10 Finland

Ileus, unspecified

4.6

35.5

127

281

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

20.9

35.2

6403

FHL

Ileocal resection

46.9

34.7

UJF30

SPAT

8.4

34.5

1380

FHL

Colonoscopy, left side

32.3

34.3

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

34.0

128

298

K61.0

ICD-10 Finland

Anal abscess

3.4

34.0

170

507

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

33.9

815

5097

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

33.8

353

1632

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

4.3

33.5

127

298

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

33.3

1066

7179

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

33.2

2293

18058

Z93

ICD-10 Finland

Artificial opening status

11.1

33.1

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.5

32.9

120

271

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

32.4

435

2238

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.2

32.3

177

566

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

32.2

2937

24185

WX402

NOMESCO Finland

General anaesthesia

1.5

32.0

1071

7281

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

8.3

31.3

6525

FHL

Enterostomy occlusion

39.2

31.1

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.5

31.1

262

1091

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

30.9

299

1333

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

12.3

30.9

A06AC51

ATC

ispaghula, combinations; systemic

2.2

30.2

308

1410

J01DB01

ATC

cefalexin; oral

1.4

29.8

5698

52240

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

16.1

29.7

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.4

29.5

265

1138

E0000UV

ATC

1.3

29.4

2504

20310

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.2

28.8

177

JF1AD

NOMESCO Finland

Small bowel CT

7.5

28.7

JF2AB

NOMESCO Finland

Colongraphy with X-ray

9.7

28.5

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

29.4

28.4

JHD00

NOMESCO Finland

Anal dilatation

5.9

27.9

135

C05AA01

ATC

hydrocortisone; rectal, topical

2.1

27.8

311

1481

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

282.5

27.8

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

282.5

27.8

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

27.6

303

1434

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

27.5

374

1934

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.2

27.4

145

453

Y0599

ICD-8 Finland

Investigation of digestive system

3.9

27.1

114

296

D07AC01

ATC

betamethasone; topical

1.4

27.0

2018

15983

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

12.7

27.0

6408

FHL

Colectomy and ileostomy

272.0

26.7

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

13.6

26.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

26.5

1230

8943

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

26.2

267

1221

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

26.1

306

1491

ZXC86

NOMESCO Finland

Use of endoscopic device

6.8

25.7

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

8.5

25.6

UJD02

NOMESCO Finland

Gastroscopy

2.2

25.2

266

1236

SPAT1262

SPAT

Handing over of treatment supplies

1.5

25.0

990

6961

UJH02

NOMESCO Finland

Anoscopy

2.2

24.9

264

1230

JAH00

NOMESCO Finland

Laparotomy

2.7

24.9

178

678

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

24.8

371

1989

M05BA04

ATC

alendronic acid; oral

2.0

24.4

322

1646

K76.9

ICD-10 Finland

Liver disease, unspecified

3.5

24.2

114

327

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.7

24.0

105

283

Z94.4

ICD-10 Finland

Liver transplant status

7.9

23.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

23.2

482

2880

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

23.0

235

1076

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

20.1

22.9

J01FA10

ATC

azithromycin; systemic

1.3

22.6

3978

35233

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

22.5

184

757

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

22.4

598

3826

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

22.4

403

2300

A07AA02

ATC

nystatin; oral

2.0

22.4

310

1614

WW200

NOMESCO Finland

Immunization

2.3

21.9

201

875

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.5

21.8

K56.0

ICD-10 Finland

Paralytic ileus

4.6

21.7

163

UJF32

SPAT

3.2

21.6

113

352

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

21.0

241

1164

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

19.4

20.8

L01BB01

ATC

11.6

20.7

5604

FHL

Vascular preparation or cannulation in the operating room

9.4

20.5

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.9

20.3

126

442

ZXD05

NOMESCO Finland

Urgent procedure

1.3

20.1

1885

15313

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

20.0

161

656

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

19.9

182

795

ICD-10 Finland

2.6

19.8

144

557

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

19.6

2387

20064

107

Kela drug reimbursment

Pernicious anaemia

3.1

19.5

107

346

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

19.5

2054

16949

B04AD01

ATC

15.6

19.2

L88

ICD-10 Finland

Pyoderma gangrenosum

11.7

19.2

SPAT1131

SPAT

Colonoscopy

2.3

19.2

178

783

JJC00

NOMESCO Finland

Allogenic transplantation of liver

8.9

19.0

D07AD01

ATC

clobetasol; topical

1.4

18.8

823

5890

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

18.7

5779

61102

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

18.7

180

Z3231

NOMESCO Finland

Registered nurse

1.3

18.5

1558

12440

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

9.3

18.5

R01AD08

ATC

fluticasone; nasal

1.3

18.5

1760

14301

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.4

18.3

155

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

8.7

18.3

A02BA02

ATC

ranitidine; systemic

1.4

18.3

956

7071

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

18.1

517

3364

E86

ICD-10 Finland

Volume depletion

2.8

18.1

120

438

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.6

18.0

SPAT1263

SPAT

Sampling

1.3

17.8

2567

21970

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

11.5

17.4

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

5.4

17.4

6402

FHL

Small bowel resection

10.7

17.4

D99

ICPC

Disease digestive system other

3.6

17.3

223

Z43.2

ICD-10 Finland

Attention to ileostomy

10.0

17.3

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

9.0

17.3

D07AC13

ATC

mometasone; topical

1.3

17.1

1673

13624

E000001

ATC

1.3

17.0

1204

9353

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

7.7

17.0

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

6.6

17.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.9

2016

16837

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

16.7

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

16.4

203

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.4

16.2

236

SPAT1255

SPAT

Intravenous administration of medicine

1.7

16.1

337

2019

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

16.0

483

3184

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.4

16.0

228

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

18.5

16.0

J01FA06

ATC

roxithromycin; oral

1.2

16.0

2331

19913

J05AB01

ATC

aciclovir; systemic

1.3

15.8

1136

8837

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.4

15.8

220

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

10.4

15.6

1470

FHL

Rectoscopy

4.2

15.4

139

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

15.4

363

2252

JHD20

NOMESCO Finland

Incision of fistula-in-ano

3.1

15.3

280

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

15.3

182

895

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

17.7

15.1

J01DA01

ATC

[U] cefalexin; systemic

1.2

15.1

3974

36061

B80

ICPC

Iron deficiency anaemia

2.6

15.1

113

445

K62.4

ICD-10 Finland

Stenosis of anus and rectum

7.8

15.0

R01AD12

ATC

fluticasone furoate; nasal

1.3

14.9

1884

15793

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

6.0

14.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

14.8

2533

21980

J02AC01

ATC

fluconazole; systemic

1.2

14.7

2282

19580

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

14.7

200

1042

6455

FHL

Perianal fistula surgery

5.4

14.6

JFA76

NOMESCO Finland

Closure of fistula of small intestine

80.2

14.6

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

6.3

14.5

6522

FHL

Ileostomy

150.3

14.5

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.7

14.1

358

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

14.1

385

2476

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

17.5

13.8

A98

ICPC

Health maint/preventive medicine

1.4

13.7

7059

68667

J01CA04

ATC

amoxicillin; systemic

1.2

13.6

5585

52689

Z90.4

ICD-10 Finland

Acquired absence of other parts of digestive tract

75.3

13.6

L04AB02

ATC

infliximab; parenteral

+∞

13.5

D29

ICPC

Digestive symptom/complaint other

2.4

13.3

113

480

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.1

13.1

150

727

J05AB11

ATC

valaciclovir; oral

1.4

13.0

689

5094

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

13.0

208

1150

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

13.0

698

5176

K83.1

ICD-10 Finland

Obstruction of bile duct

3.0

12.9

239

6404

FHL

Hemicolectomy on the right

13.0

12.9

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.4

12.8

106

444

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.9

12.8

J01AA02

ATC

doxycycline; systemic

1.2

12.8

4892

45646

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.6

12.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

12.7

303

1885

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

12.7

477

3307

K61.1

ICD-10 Finland

Rectal abscess

5.1

12.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

12.7

254

1506

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

12.6

465

3207

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

12.6

353

2292

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

12.6

410

2757

6437

FHL

Rectum resection and sphincter-sparing through-anastomosis

+∞

12.5

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

12.5

375

2474

R01AD09

ATC

mometasone; nasal

1.2

12.5

2804

24883

JFH31

NOMESCO Finland

Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

130.2

12.4

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

12.4

1563

13059

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

2.5

12.3

388

RD210

NOMESCO Finland

2.2

12.1

118

537

H20.1

ICD-10 Finland

Chronic iridocyclitis

3.0

12.0

224

B02.9

ICD-10 Finland

Zoster without complication

1.7

11.9

240

1424

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.5

11.9

155

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

11.9

JFB20

NOMESCO Finland

Ileocaecal resection

4.2

11.8

106

D01

ICPC

Abdominal pain/cramps general

1.4

11.8

583

4254

L52

ICD-10 Finland

Erythema nodosum

3.8

11.8

131

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

11.8

441

3056

B01AB10

ATC

tinzaparin; parenteral

1.6

11.6

317

2045

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

11.5

141

707

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

11.5

1208

9862

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

11.5

199

3184

5589X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis

8.1

11.5

WZC30

NOMESCO Finland

Teaching

1.4

11.5

659

4936

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.1

11.5

192

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

11.5

282

1770

A03BA03

ATC

hyoscyamine; oral

3.5

11.3

151

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

11.2

478

3395

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

11.2

508

3654

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

4.5

11.1

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

2.2

11.1

104

467

J01FA09

ATC

clarithromycin; systemic

1.2

11.1

1844

15849

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

6.4

11.0

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

11.0

160

857

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

9.2

11.0

D07XC01

ATC

betamethasone, combinations; topical

1.4

10.8

599

4460

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

10.8

166

905

A07AA11

ATC

rifaximin; oral

6.9

10.8

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

3.4

10.8

152

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

6.4

10.7

JJ5AT

NOMESCO Finland

9.6

10.7

JG1JB

NOMESCO Finland

Defekography with X-ray

3.9

10.7

112

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

12.9

10.6

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

10.6

125

620

SPAT1125

SPAT

Stoma care and guidance

2.8

10.6

227

ZX112

NOMESCO Finland

Subcutaneous

2.1

10.4

109

512

5694X

ICD-9 Finland

Other disorders of intestine, Other specified disorders of rectum and anus

110.2

10.4

N05CF01

ATC

zopiclone; oral

1.2

10.4

1579

13438

K90.0

ICD-10 Finland

Coeliac disease

1.9

10.3

154

832

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.2

10.3

101

462

JD1AB

NOMESCO Finland

Gastro-duodenography with X-ray

16.0

10.3

6451

FHL

Dilatation

3.6

10.3

126

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

32.5

10.3

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

10.6

10.2

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

8.8

10.2

-44

ICPC

Preventive immunization/medic

1.5

10.1

363

2491

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

10.1

386

2684

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

10.1

104

484

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

10.1

1035

8422

K62.9

ICD-10 Finland

Disease of anus and rectum, unspecified

4.1

10.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

9.9

1896

16484

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

4.1

9.9

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

9.9

1547

13197

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

7.0

9.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

9.8

232

1445

5781B

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]

8.7

9.8

UKC02

NOMESCO Finland

Cystoscopy

1.3

9.7

681

5262

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

9.5

9.7

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.8

9.7

161

905

SPAT1325

SPAT

Vaccination

1.2

9.7

1677

14436

N20.1

ICD-10 Finland

Calculus of ureter

1.7

9.7

191

1130

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

9.7

166

944

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

5.1

9.7

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

9.6

1607

13786

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.1

9.5

100

472

WX004

NOMESCO Finland

Patient-controlled sedation

3.6

9.5

115

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

9.5

815

6484

JGB60

NOMESCO Finland

Excision of rectum and ileoanal anastomosis

100.1

9.4

M03BX02

ATC

tizanidine; oral

1.2

9.4

3921

36349

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

9.4

152

846

5609X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction

6.6

9.4

54099

ICD-8 Finland

Acute appendicitis, Without mention of peritonitis

0.4

9.4

831

JFB96

NOMESCO Finland

Other partial excision of intestine

17.5

9.4

M075, K515

ICD-10 Finland

+∞

9.4

JFG70

NOMESCO Finland

Conversion of continent ileostomy to conventional ileostomy

+∞

9.4

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.2

9.3

148

56398

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Alia definita

21.7

9.3

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

9.3

1580

A01AB09

ATC

miconazole; local oral

1.4

9.3

391

2772

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

5.8

9.3

A02BA03

ATC

famotidine; systemic

1.8

9.3

159

902

J01AA04

ATC

lymecycline; systemic

1.3

9.2

765

6057

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

9.2

150

838

J01MA14

ATC

moxifloxacin; systemic

1.4

9.2

415

2987

WW500

NOMESCO Finland

Blood transfusion

1.7

9.1

179

1060

N05AH02

ATC

clozapine; systemic

0.4

9.0

756

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

9.0

158

903

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

9.0

337

2340

4AC05

NOMESCO Finland

18.6

8.9

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.9

1600

13812

78570

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Melaena (not of newborn)

6.1

8.9

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

8.9

868

7015

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

8.9

619

4781

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

12.5

8.8

M25.5

ICD-10 Finland

Pain in joint

1.2

8.8

1558

13422

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

448

589

7.98

321.39

2.0

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

267

174

15.81

308.55

2.0

1.6

au/ml

84.3

163.1

0.84

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4770

30158

2.34

308.42

3.9

2.8

ug/l

98.5

117.3

5.88

4562

28348

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3987

22850

2.41

307.65

4.8

3.2

u/l

29.9

34.1

4.70

3674

21791

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

736

173

46.52

307.65

2.7

2.9

au/ml

119.6

149.2

0.29

104

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5750

25769

4.87

307.65

3.7

2.2

nmol/l

74.7

74.6

0.12

5567

23652

(3002179) Metamyelocytes/100 leukocytes in Blood

1726

4816

4.25

307.65

5.7

4.0

0.3

0.6

6.75

360

1042

(3013650) Neutrophils [#/volume] in Blood by Automated count

6763

38377

4.86

307.65

15.1

9.1

e9/l

3.9

4.1

12.22

6302

33607

(3022096) Basophils/100 leukocytes in Blood

6033

30294

4.49

307.65

13.5

6.1

0.7

24.47

5826

28418

(3024561) Albumin [Mass/volume] in Serum or Plasma

6435

25740

7.34

307.65

9.4

4.9

g/l

36.9

36.2

31.44

6238

24013

(3001604) Monocytes [#/volume] in Blood

6529

33349

5.25

307.65

13.3

5.9

e9/l

0.6

3.18

6076

29067

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1718

2062

10.21

307.65

1.7

1.6

iu/ml

3.6

5.2

0.14

369

426

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

369

209

18.42

307.65

2.4

1.9

mg/l

9.4

9.3

0.03

313

168

(3013115) Eosinophils [#/volume] in Blood

6621

34665

5.24

307.65

13.6

6.2

e9/l

0.2

2.22

6188

30725

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

850

179

52.70

307.65

3.3

3.5

mg/l

8.6

7.1

2.80

712

131

(3025941) Bacteria identified in Stool by Culture

1412

4005

4.03

307.65

1.5

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

333

144.42

307.65

3.1

2.5

mg/l

23.2

17.2

2.25

313

(42870588) Differential panel, method unspecified - Blood

5108

22103

4.33

307.65

11.8

6.0

—

(3019198) Lymphocytes [#/volume] in Blood

6573

34537

5.10

307.65

13.4

5.9

e9/l

1.9

2.0

8.36

6164

30711

(3019069) Monocytes/100 leukocytes in Blood

6129

31459

4.48

307.65

13.7

6.3

8.7

8.5

8.61

5931

29665

(3022145) Colonoscopy Study observation

5257

6441

20.03

307.65

2.1

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

6139

32139

4.35

307.65

12.8

5.8

57.0

56.7

1.40

5941

30280

(3048689) Calprotectin [Mass/mass] in Stool

6566

8206

32.68

307.65

7.4

1.8

ug/g

237.1

109.1

76.95

6275

6404

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3793

14898

3.81

307.65

3.8

2.1

mg/l

2.8

0.40

3458

12821

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

323

139.91

307.65

3.2

2.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7166

48742

4.14

307.65

7.1

3.8

mm/h

11.3

10.4

7.21

6839

45620

(3007566) Smooth muscle Ab [Titer] in Serum

914

1896

5.29

307.65

1.8

1.2

titre

65.8

131.6

1.41

185

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

756

1335

6.12

307.65

4.9

3.6

56.9

57.0

0.12

756

1335

(3006315) Basophils [#/volume] in Blood

6543

33478

5.27

307.65

13.4

5.9

e9/l

0.0

4.54

6096

29165

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2598

3940

9.09

307.65

2.2

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

898

1870

5.26

307.65

1.7

1.2

titre

462.9

999.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

875

1385

6.93

307.65

3.3

6.1

iu/ml

815.6

787.6

0.04

194

(3025159) Blasts/100 leukocytes in Blood

1670

4755

4.13

307.65

6.2

4.3

0.0

0.2

1.06

382

1111

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7771

49530

8.29

307.65

17.1

7.1

u/l

74.9

76.4

2.59

7644

46896

(3006504) Eosinophils/100 leukocytes in Blood

6102

31287

4.44

307.65

13.4

6.0

2.8

2.9

0.52

5900

29304

(3021440) Promyelocytes/100 leukocytes in Blood

1744

5001

4.14

307.65

6.2

4.3

0.1

0.2

2.47

445

1322

(3021589) Normoblasts [#/volume] in Blood

5058

29732

2.75

307.65

16.4

8.9

e9/l

0.0

2.42

4488

24339

(3002030) Lymphocytes/100 leukocytes in Blood

6177

32623

4.34

307.65

13.5

6.0

28.6

28.7

0.27

5971

30615

(3017143) Hepatitis C virus Ab [Presence] in Serum

2313

9807

2.87

307.65

1.5

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3322

15826

2.81

307.65

9.7

4.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1809

5253

4.11

307.65

6.0

4.2

0.7

0.9

3.44

475

1426

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2678

13468

2.45

290.00

1.6

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1881

8116

2.70

279.79

2.7

2.6

22.4

23.8

3.93

1642

7015

(3028026) IgM [Mass/volume] in Serum or Plasma

1168

3989

3.24

265.00

2.0

1.8

g/l

1.2

1.3

0.48

1101

3680

(3022948) Iron [Moles/volume] in Serum or Plasma

2048

9545

2.51

257.36

2.7

2.5

umol/l

13.4

13.8

1.84

1954

8908

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1927

8765

2.55

254.70

2.7

2.5

g/l

2.4

5.51

1831

8167

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4872

32636

2.17

252.97

7.7

6.1

umol/l

10.9

11.2

1.31

4682

30970

(3005719) IgG [Mass/volume] in Serum or Plasma

1335

5195

2.87

239.20

2.7

2.6

g/l

11.6

10.5

21.67

1250

4770

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

357

520

7.12

233.31

1.5

1.2

titre

290.9

204.1

1.00

137

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

356

520

7.10

232.05

1.5

1.2

titre

383.2

167.5

0.71

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1392

5628

2.76

231.41

3.5

2.3

g/l

0.2

9.95

1317

5267

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

162

23.92

226.70

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8085

69407

5.04

224.81

24.5

12.3

mg/l

15.5

22.7

121.73

7189

53975

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

565

1322

4.51

221.07

1.6

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3261

19983

2.03

200.19

3.9

2.6

u/l

59.7

56.8

2.02

3083

18547

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

588

1549

4.01

196.18

1.3

u/ml

270.6

257.4

0.43

342

1006

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

607

1646

3.90

194.43

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

3969

26248

1.97

194.04

2.4

2.0

—

(3037522) Nuclear Ab [Titer] in Serum

1889

9500

2.27

193.00

1.7

1.3

titre

558.6

524.0

0.34

508

1793

(3024980) IgG subclass 4 [Mass/volume] in Serum

484

1139

4.45

187.54

2.3

1.5

g/l

0.8

0.07

397

857

(40758558) Short blood count panel - Blood

2778

16608

2.00

178.15

10.3

7.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

577

1648

3.69

170.99

1.8

1.4

iu/ml

5.0

15.2

1.67

(3003327) Ova and parasites identified in Stool by Light microscopy

727

2440

3.17

166.78

1.8

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2402

14056

1.99

160.62

1.7

1.4

g/l

2.5

2.3

2.41

1739

8954

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

296

530

5.75

157.45

2.4

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

434

1090

4.14

154.02

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

648

2128

3.22

153.86

2.0

1.6

titre

390.5

404.4

0.04

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

375

865

4.49

148.68

1.4

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

441

1164

3.94

146.08

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

348

768

4.68

145.78

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

344

755

4.71

145.07

1.7

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

731

2661

2.91

144.79

1.8

1.5

u/ml

5.6

15.8

2.11

(3024522) Salmonella sp identified in Specimen by Organism specific culture

343

753

4.71

144.60

1.7

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

519

1546

3.51

143.89

1.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

590

1905

3.25

143.86

1.3

1.1

—

(3032080) INR in Blood by Coagulation assay

3477

23569

1.81

143.58

8.5

7.9

inr

1.1

1.2

7.18

1226

7132

(3014765) Yersinia sp identified in Stool by Organism specific culture

586

1895

3.25

142.49

1.3

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7456

64313

2.38

141.96

19.3

11.1

ml/min/173m2

89.7

87.5

15.22

6518

52956

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

582

1879

3.25

141.89

1.3

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

736

2723

2.87

141.38

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

363

867

4.33

137.54

4.1

2.9

u/ml

7.0

292.7

1.08

358

805

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

334

750

4.60

136.89

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

333

748

4.59

136.42

1.7

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2669

16898

1.85

136.21

1.8

2.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

333

752

4.57

135.51

1.7

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4067

29433

1.74

129.51

7.0

6.8

mmol/l

1.2

1.66

3405

24898

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

555

1876

3.10

124.92

5.5

3.5

u/ml

49.9

3018.9

1.29

506

1611

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

280

590

4.87

123.92

1.3

1.2

u/l

57.2

62.9

0.60

191

402

(3002385) Erythrocyte distribution width [Ratio]

6922

58940

1.98

121.63

26.1

14.9

13.7

13.5

12.59

6876

57754

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8116

74027

3.59

119.20

21.5

9.3

u/l

27.3

28.1

3.06

8044

71793

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

692

2734

2.67

116.48

1.2

1.4

—

(40768441) Liver Pathology biopsy report

236

459

5.26

114.56

1.7

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3682

26639

1.68

111.64

6.2

mmol/l

1.2

3.45

3400

24339

(40761536) Microorganisms panel - Urine sediment

1122

5610

2.15

110.70

4.2

3.6

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

21.22

109.52

1.1

u/ml

26.0

41.9

0.49

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

21.22

109.52

1.1

u/ml

20.1

26.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2017

12437

1.82

107.72

2.4

1.6

pmol/l

33462181.8

32375271.0

0.03

1817

10607

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

103

12.55

105.13

2.4

1.7

mg/l

2.1

1.5

2.44

(3037467) Urinalysis macro (dipstick) panel - Urine

5567

45216

1.68

104.65

4.6

3.9

—

(3018418) pH of Serum or Plasma

2596

17363

1.72

103.77

4.1

4.2

7.4

0.17

526

3428

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

155

220

7.16

103.43

1.7

1.8

u/ml

4513.1

17607.7

0.39

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1363

7518

1.97

102.27

4.1

2.8

umol/l

6.6

7.7

1.82

1204

6524

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1165

6141

2.04

99.15

3.4

2.5

u/l

39.9

48.3

0.49

1042

5292

(3019309) Folate [Moles/volume] in Red Blood Cells

1663

9886

1.85

98.95

2.1

1.7

nmol/l

1172.5

1162.4

0.15

1129

7664

(3023368) Bacteria identified in Blood by Culture

2392

15854

1.71

97.69

4.7

4.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

182

329

5.63

95.71

17.2

26.9

ug/l

133.4

115.5

2.40

165

261

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

324

940

3.54

93.11

1.1

g/l

1.5

0.51

302

846

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

181

343

5.37

90.42

1.4

1.2

u/l

78.8

90.2

0.80

149

297

(3033658) Prothrombin time (PT) actual/Normal

2443

16602

1.66

89.21

5.9

3.9

94.1

92.1

4.17

2380

16188

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

176

332

5.39

88.37

1.4

1.2

u/l

21.2

20.4

0.05

146

283

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3231

23671

1.59

86.15

2.0

1.9

pmol/l

95.5

96.8

0.79

1944

12792

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2359

16020

1.66

85.72

1.3

u/ml

1.5

1.8

0.50

600

4516

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

174

340

5.20

84.00

1.8

1.5

u/l

5.3

5.7

0.13

166

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1149

6446

1.91

80.44

1.3

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7594

69178

1.99

76.44

18.5

13.7

mmol/l

3.9

4.0

37.00

7425

67290

(3019550) Sodium [Moles/volume] in Serum or Plasma

7572

68915

1.97

76.34

18.3

13.6

mmol/l

139.5

139.7

11.42

7415

67182

(3004716) Salmonella sp identified in Stool by Organism specific culture

773

3847

2.11

75.74

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

192

467

4.18

70.89

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

191

472

4.12

69.04

1.2

—

(40768797) Stomach Pathology biopsy report

1379

8543

1.73

68.68

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

289

955

3.10

67.21

3.2

0.8

1.4

3.65

217

744

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

958

5359

1.89

66.89

5.0

4.2

ug/l

18.1

30.8

0.52

748

4261

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

121

210

5.83

66.45

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

191

494

3.93

64.87

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

4080

32743

1.48

64.75

3.8

3.3

estimate

0.0

0.66

1176

5964

(3013826) Glucose [Moles/volume] in Serum or Plasma

4547

37277

1.48

64.74

5.3

4.7

mmol/l

6.6

0.29

4273

34571

(3035350) Ketones [Presence] in Urine by Test strip

4043

32392

1.48

64.68

3.7

3.3

estimate

0.0

1.28

1176

5970

(3006922) Hepatitis E virus Ab [Presence] in Serum

200

538

3.78

64.25

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

440

1851

2.45

64.20

1.2

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

191

499

3.89

63.96

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

4037

32441

1.47

62.94

4.9

4.5

estimate

0.0

0.80

1206

6185

(3017732) Neutrophils [#/volume] in Blood

853

4713

1.90

61.62

2.9

2.7

e9/l

4.2

0.01

619

3846

(3029937) Albumin [Presence] in Urine by Test strip

2364

17117

1.53

61.26

4.2

3.6

estimate

0.0

0.09

1176

5929

(40761511) CBC panel - Blood by Automated count

7830

72991

2.02

60.21

18.5

11.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2495

18407

1.50

58.63

3.5

2.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

379

1587

2.45

55.79

1.3

1.5

u/ml

22.2

20.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

377

1592

2.43

54.47

1.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3238

25438

1.44

54.04

3.9

3.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

352

1453

2.48

53.43

1.3

1.5

u/ml

107.9

110.7

0.22

287

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

7.01

52.81

1.4

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

294

1119

2.69

52.72

5.2

3.7

u/ml

123.1

564.6

1.18

267

1032

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1023

6278

1.72

51.56

2.3

2.2

nmol/l

329.0

372.2

11.41

950

5770

(3041672) Baker's yeast Ab [Presence] in Serum

13.12

49.35

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

148

391

3.83

48.84

1.1

miu/ml

1600.2

1466.9

0.68

148

391

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

185

570

3.30

48.37

1.1

mg/l

282.7

284.4

0.10

166

519

(3052851) Hemolysis interference index of Serum or Plasma

402

1874

2.20

46.07

3.3

3.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

283

1137

2.54

45.48

2.7

3.0

u/ml

892.5

1061.3

0.12

(3021960) Folate [Moles/volume] in Serum or Plasma

1794

12955

1.49

44.66

1.6

1.5

nmol/l

20.1

20.2

0.05

1605

11326

(3017354) Segmented neutrophils/100 leukocytes in Blood

179

579

3.14

43.22

3.2

3.3

58.8

57.3

0.37

111

371

(3007461) Platelets [#/volume] in Blood

8185

78588

2.43

42.62

33.3

17.9

e9/l

270.4

253.2

91.01

8122

76797

(3035941) MCH [Entitic mass]

8186

78658

2.41

41.56

33.1

17.8

30.4

30.2

14.22

8157

77743

(3024731) MCV [Entitic volume]

8186

78664

2.41

41.44

33.1

17.8

91.3

90.4

63.21

8157

77752

(3026361) Erythrocytes [#/volume] in Blood

8186

78677

2.40

41.20

33.2

17.9

e12/l

4.5

4.6

29.21

8107

76730

(3010813) Leukocytes [#/volume] in Blood

8187

78700

2.40

41.02

33.3

17.9

e9/l

6.8

6.7

3.98

8110

76722

(3027945) Reticulocytes/100 erythrocytes in Blood

967

6189

1.64

40.95

3.7

2.7

1.8

1.31

884

5532

(3000963) Hemoglobin [Mass/volume] in Blood

8186

78704

2.39

40.69

33.4

18.0

g/l

136.4

137.9

18.28

8155

77779

(3032057) Clostridioides difficile [Presence] in Stool

100

6.54

40.32

2.2

2.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1117

7460

1.57

39.51

8.9

7.7

mmol/l

104.8

104.5

1.70

1102

7296

(3008898) HLA-B27 [Presence]

521

2834

1.89

38.96

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1303

9037

1.52

38.80

2.2

2.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4859

42261

1.35

38.69

4.3

3.9

e6/l

1193.4

1324.6

0.04

532

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

383

1878

2.09

38.52

3.9

4.0

mg/l

1.4

0.91

353

1756

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

109

280

3.93

37.49

1.2

1.1

u/l

13.4

24.3

3.24

220

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

108

282

3.87

36.32

1.2

1.1

u/l

66.6

90.2

2.49

229

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

270

1180

2.33

36.10

1.2

titre

146.7

211.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

170

600

2.87

35.26

3.5

3.8

—

(4035726)

820

5222

1.63

35.17

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

249

4.01

35.08

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

249

4.01

35.08

1.5

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

2383

18887

1.36

33.48

3.4

3.1

e6/l

76.4

89.6

0.22

1928

14409

(3023520) Reticulocytes [#/volume] in Blood

717

4480

1.66

33.08

2.9

2.7

e9/l

74.3

70.9

1.32

553

3346

(3030467) Casts [#/volume] in Urine by Automated count

2199

17274

1.37

32.50

3.3

3.0

e6/l

0.4

0.43

1732

12895

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1136

7927

1.50

32.38

6.2

6.5

mmol/l

1.0

1.51

1076

7465

(3020961) Endomysium IgA Ab [Titer] in Serum

586

3495

1.73

32.17

1.1

titre

48.8

207.1

—

104

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

112

326

3.47

32.15

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

260

3.76

31.48

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

2519

20318

1.34

31.05

2.8

2.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

112

335

3.37

30.83

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

270

1263

2.18

30.68

1.1

—

(36304419) Bacteria [Presence] in Urine

2150

17022

1.35

29.72

3.2

2.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3626

30996

1.30

28.83

4.7

3.9

—

(3018095) Leukocytes [#/volume] in Urine

2721

22417

1.32

28.31

3.8

3.5

e6/l

77.9

78.3

0.01

2046

15627

(3000850) Epithelial cells [#/volume] in Urine

1696

13025

1.38

28.22

2.7

2.5

e6/l

5.7

5.5

0.13

1528

11434

(3026782) Osmolality of Urine

1587

12058

1.39

28.19

2.9

2.7

mosm/kgh2o

555.6

555.8

0.01

1411

10305

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

273

3.51

27.86

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

220

3.80

27.42

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

258

1254

2.09

26.59

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

101

315

3.23

26.06

2.2

1.8

umol/l

2.1

1.9

0.97

296

(3009542) Hematocrit [Volume Fraction] of Blood

7057

66395

1.39

25.86

22.0

13.0

40.3

40.6

2.71

5333

52152

(3020779) Urea [Moles/volume] in Serum or Plasma

792

5394

1.52

25.02

8.9

8.4

mmol/l

8.6

9.1

1.25

753

5175

(3020393) Adenovirus Ag [Presence] in Stool

6.33

24.76

1.8

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1318

9905

1.39

24.65

4.1

3.7

mmol/l

0.8

6.37

1221

9328

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1858

14736

1.33

24.60

1.9

1.8

mg/l

1.2

1.1

0.75

1438

10987

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

876

6162

1.47

23.55

3.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5451

49699

1.27

23.55

4.4

3.0

u/l

53.1

45.1

8.00

5171

47139

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

134

518

2.61

23.47

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

162

4.04

23.43

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2413

19986

1.29

23.00

3.4

3.3

mmol/l

2.3

2.4

1.11

2153

17799

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

710

4815

1.52

22.82

3.8

3.9

mmol/l

1.2

0.74

627

4235

(4062490)

171

757

2.28

22.32

1.3

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1421

11028

1.35

21.42

1.3

u/ml

6.8

10.7

1.88

519

4561

(3027135) IgG subclass 1 [Mass/volume] in Serum

169

758

2.25

21.40

1.2

1.4

g/l

8.1

6.6

4.14

104

524

(3024139) IgG subclass 3 [Mass/volume] in Serum

169

758

2.25

21.40

1.2

1.4

g/l

0.4

0.10

101

524

(3028192) IgG subclass 2 [Mass/volume] in Serum

169

759

2.25

21.33

1.2

1.4

g/l

3.0

0.01

101

527

(3000570) Elastase.pancreatic [Mass/mass] in Stool

315

1777

1.80

20.94

1.6

1.4

ug/g

281.5

283.0

0.05

192

1012

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1235

9410

1.37

20.93

2.0

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

4.86

20.55

1.8

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1899

15466

1.29

20.12

2.7

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

263

3.06

19.01

3.6

2.7

—

(3002032) Base excess in Venous blood by calculation

757

5425

1.43

18.28

5.1

4.2

mmol/l

1.7

1.8

0.46

600

4409

(3019225) pH of Specimen

775

5587

1.43

18.11

4.0

4.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

342

2067

1.68

17.85

1.1

u/ml

2.4

6.6

2.19

307

(3026008) Bacteria identified in Urine by Culture

1987

16557

1.26

17.05

3.0

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2620

22546

1.24

16.80

3.4

3.2

ng/l

45.1

52.7

0.29

1613

13517

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1459

11731

1.29

16.66

1.3

iu/ml

23.2

30.9

1.20

452

3622

(36660697) Celiac disease serology panel - Serum

784

5750

1.40

16.57

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1024

7846

1.35

16.47

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

747

5446

1.41

16.34

5.1

4.2

kpa

5.8

0.02

717

5282

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

387

2499

1.58

15.50

1.9

1.8

g/l

1.4

1.5

0.57

342

2165

(3000494) Fungus identified in Specimen by Culture

1004

7790

1.33

14.75

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

404

2688

1.53

14.17

1.3

1.2

u/ml

0.3

1.1

3.20

239

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

868

6631

1.34

14.15

3.8

4.5

u/l

224.5

237.6

3.17

825

6297

(3022217) INR in Platelet poor plasma by Coagulation assay

905

6975

1.33

13.89

20.8

20.3

inr

1.2

1.3

0.39

176

1078

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

331

2143

1.57

13.15

1.5

1.7

g/l

1.2

0.01

313

2039

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1286

10490

1.27

12.78

2.8

2.6

e6/l

0.9

1.0

0.37

760

5869

(3020717) Zinc [Moles/volume] in Serum or Plasma

376

2.35

12.66

1.6

1.5

umol/l

25.7

24.8

0.10

359

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1209

9804

1.27

12.61

3.0

2.8

e6/l

2.4

0.11

684

5203

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5527

51845

1.19

12.58

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

433

2997

1.47

12.55

5.5

4.5

mmol/l

24.0

24.1

0.38

404

2695

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

319

2077

1.56

12.38

1.5

1.7

g/l

0.2

1.65

300

1973

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

826

6398

1.32

12.20

1.9

1.7

—

(3000991) Gas panel - Venous blood

678

5103

1.36

12.15

10.2

9.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

532

3850

1.41

12.12

8.1

7.9

mmol/l

24.5

24.7

1.05

525

3828

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

243

1491

1.65

12.08

1.7

1.6

—

(40768443) Skin Pathology biopsy report

395

2712

1.48

11.94

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

830

6464

1.32

11.78

1.9

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

322

2125

1.54

11.77

1.9

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

417

2.22

11.57

3.1

2.6

92.6

96.0

0.46

388

(3028433) Virus identified in Specimen by Culture

218

2.72

11.51

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

406

2842

1.45

11.13

1.8

1.9

u/l

38.3

39.4

0.62

357

2568

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

559

4146

1.37

11.00

4.1

4.2

ng/l

87.9

90.1

0.20

503

3663

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

126

658

1.93

10.88

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

210

1278

1.66

10.82

2.3

2.4

16.9

16.8

0.12

105

613

(3004588) Protein electrophoresis panel - Serum or Plasma

484

3556

1.38

10.11

2.4

2.3

—

(3051651) Icteric interference index of Serum or Plasma

383

2.18

10.05

4.3

3.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

186

1120

1.68

10.02

2.3

umol/l

12.8

6.5

1.89

146

818

(3051611) Lipemic interference index of Serum or Plasma

113

586

1.94

10.00

4.1

3.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

275

1820

1.53

9.98

2.5

2.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

581

4441

1.33

9.40

4.5

3.6

kpa

4.5

4.7

1.48

555

4290

(3042733) HLA Ab [Presence] in Serum

279

2.34

9.37

3.0

5.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

213

2.55

9.33

2.0

3.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

317

2195

1.46

9.25

2.0

ug/l

6.8

2.4

0.47

281

1966

(3012501) Base excess in Blood by calculation

223

1434

1.57

9.24

3.3

4.1

mmol/l

2.4

0.02

145

959

(3020630) Protein [Mass/volume] in Serum or Plasma

580

4445

1.33

9.22

2.5

2.6

g/l

67.3

66.8

0.96

552

4114

(3013290) Carbon dioxide [Partial pressure] in Blood

223

1435

1.57

9.21

3.3

4.1

kpa

4.9

5.0

0.76

217

1412

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

185

1140

1.64

9.15

1.1

u/ml

2.1

3.6

2.24

601

(3002173) Hemoglobin [Mass/volume] in Arterial blood

699

5505

1.29

9.11

8.8

9.0

g/l

121.5

123.4

1.62

675

5306

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

659

5150

1.30

9.10

2.9

2.5

ml/min/173m2

71.6

71.2

0.08

274

1942

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

132

2.96

9.01

3.2

3.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

214

1373

1.57

8.97

1.2

1.3

u/ml

4.9

5.9

0.11

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

422

2.05

8.93

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

222

1441

1.56

8.85

3.3

4.1

kpa

8.9

8.8

0.34

216

1417

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1794

15671

1.18

8.74

1.6

—

(1616796) Gas panel - Central venous blood

211

1359

1.57

8.71

3.3

3.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

172

1055

1.64

8.69

1.9

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.32

8.67

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

494

3735

1.34

8.63

4.9

3.6

kpa

5.0

5.1

2.84

456

3470

(3047181) Lactate [Moles/volume] in Blood

276

1888

1.48

8.60

5.6

6.6

mmol/l

1.3

0.24

246

1659

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

224

1469

1.54

8.54

1.8

1.7

—

(3010421) pH of Blood

249

1672

1.50

8.50

3.2

4.2

7.4

0.01

217

1413

(3009343) pH of Capillary blood

487

3683

1.34

8.49

4.9

3.6

7.4

0.73

443

(3016502) Oxygen saturation in Arterial blood

740

5925

1.27

8.46

8.5

96.5

95.9

2.70

709

5712

(40760888) Immunoglobulin light chains.free panel - Serum

184

1161

1.60

8.31

2.9

3.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

263

2.29

8.29

2.9

3.3

—

(3003338) MCHC [Mass/volume]

6462

62162

1.17

8.20

26.6

15.3

g/l

332.4

333.6

23.20

6442

61733

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1199

10158

1.21

8.14

3.1

3.0

mmol/l

2.4

1.10

1047

8893

(3015235) Bicarbonate [Moles/volume] in Capillary blood

221

1462

1.53

8.12

4.5

3.1

mmol/l

23.9

24.5

1.29

191

1273

(3034860) Kappa light chains.free [Mass/volume] in Serum

230

1537

1.51

8.06

3.2

3.4

mg/l

47.3

53.6

0.45

180

1238

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

274

1898

1.46

8.03

1.2

1.3

u/ml

20.3

33.1

0.37

114

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

141

839

1.69

8.03

1.8

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

372

2.05

7.99

43.9

36.6

ug/l

7.2

7.5

0.87

348

(3011325) HIV 1+2 Ab [Presence] in Serum

4.62

7.86

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

229

1539

1.50

7.82

3.2

3.4

mg/l

37.8

56.0

1.08

178

1241

(3013512) EKG study

1883

16655

1.17

7.75

3.4

3.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

293

2072

1.43

7.71

3.1

2.9

g/l

3.4

3.6

1.44

273

1966

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

250

1716

1.47

7.70

1.2

1.3

u/ml

7.8

4.8

0.39

168

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

466

3554

1.33

7.70

5.0

3.6

mmol/l

1.4

1.5

0.42

341

2624

(3028626) Oxygen [Partial pressure] in Capillary blood

207

1371

1.52

7.59

6.2

3.6

kpa

8.6

8.5

0.33

190

1264

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

252

1738

1.46

7.58

1.2

1.3

u/ml

12.2

9.7

0.27

271

(3023183) Ammonium ion [Moles/volume] in Plasma

204

1350

1.52

7.51

3.5

3.1

umol/l

30.7

35.8

3.60

176

1170

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

221

1490

1.50

7.45

3.2

3.3

ratio

1.4

2.8

0.90

130

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

133

798

1.68

7.38

1.6

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

284

2014

1.42

7.37

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

162

1022

1.60

7.37

1.4

—

(3011412) CD3 cells [#/volume] in Blood

121

708

1.72

7.37

1.9

2.5

e9/l

1.2

0.18

424

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

264

1849

1.44

7.34

3.7

3.5

u/ml

0.3

0.05

146

1041

(3002256) Pathology report gross observation

985

8277

1.22

7.25

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

239

1652

1.46

7.13

1.2

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1100

9358

1.20

7.11

2.5

2.3

29.9

29.7

0.45

1065

9094

(3001186) Copper [Moles/volume] in Serum or Plasma

181

2.44

7.06

1.4

1.3

umol/l

16.8

16.9

0.02

160

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

335

2471

1.37

6.93

2.2

2.0

—

(3003396) Base excess in Arterial blood by calculation

802

6631

1.23

6.92

8.1

8.0

mmol/l

0.7

0.9

0.82

631

5179

(3011397) Hemoglobin [Presence] in Urine by Test strip

1674

14792

1.16

6.89

3.5

3.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

655

5307

1.25

6.79

8.5

7.8

mmol/l

1.3

0.13

629

5109

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

313

2292

1.38

6.78

5.3

5.6

1.7

0.15

295

2141

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1086

9274

1.20

6.72

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

129

790

1.64

6.66

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

180

1192

1.52

6.66

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

148

938

1.59

6.65

1.6

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

263

2.14

6.63

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

310

2275

1.38

6.63

5.3

5.7

1.0

0.9

1.56

291

2129

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

515

1.80

6.57

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

515

1.80

6.57

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

515

1.80

6.57

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

304

2.05

6.57

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

304

2.05

6.57

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

304

2.05

6.57

1.6

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

304

2.05

6.57

1.6

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

1098

1.53

6.40

1.6

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

418

3227

1.31

6.39

11.4

11.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.05

6.34

1.3

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1897

17008

1.15

6.34

2.7

2.5

umol/l

3964.7

3512.5

0.21

1709

15086

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

797

6647

1.22

6.32

8.2

8.0

kpa

5.0

5.1

1.75

761

6359

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

504

3996

1.28

6.28

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

146

936

1.57

6.27

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

796

6646

1.22

6.24

8.2

8.0

kpa

12.9

12.7

0.45

761

6358

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

307

2274

1.36

6.22

2.4

2.5

94.5

92.6

0.67

283

2118

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

283

2071

1.38

6.18

2.6

2.8

180.7

181.7

0.07

265

1973

(3021901) Oxygen saturation in Capillary blood

156

1019

1.54

6.18

4.1

2.8

—

(3037756) Immunofixation for Serum or Plasma

156

1019

1.54

6.18

2.0

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

523

1.75

5.99

1.9

2.6

e6/l

450.4

525.0

0.84

433

(3005322) IgE [Units/volume] in Serum or Plasma

582

4726

1.25

5.94

1.3

u/ml

260.4

225.8

0.25

542

4384

(3039162) Centromere protein B Ab [Units/volume] in Serum

133

847

1.58

5.91

1.2

1.3

u/ml

5.8

57.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

453

3574

1.28

5.89

6.3

7.5

mmol/l

24.2

24.5

0.90

424

3328

(3027273) Bicarbonate [Moles/volume] in Venous blood

349

2665

1.32

5.80

4.2

3.5

mmol/l

24.8

25.2

1.30

334

2578

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

301

2253

1.35

5.73

2.1

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

112

692

1.63

5.65

1.9

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5444

52230

1.12

5.63

3.7

3.8

pmol/l

14.7

14.6

4.12

5012

48211

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1621

14486

1.15

5.61

3.1

3.0

ng/l

1469.1

1201.3

1.19

1347

12149

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

246

1792

1.38

5.57

2.0

mg/l

10.7

0.04

226

1683

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1266

11124

1.16

5.52

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

840

1.56

5.46

1.7

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

523

1.71

5.45

1.9

2.7

e6/l

742.2

730.4

0.05

206

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6423

62282

1.13

5.38

4.3

4.4

mu/l

1.7

2.1

4.97

6000

58018

(3036489) Thrombin time

339

2608

1.31

5.37

2.2

2.3

21.2

21.4

0.20

294

2248

(3024471) HLA-A [Type]

267

1.99

5.29

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

453

1.75

5.29

2.0

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

204

1457

1.41

5.21

1.2

1.3

u/ml

33.5

40.0

0.19

136

(3019060) Gas panel - Arterial blood

465

3741

1.26

5.19

4.6

5.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

2021

1.35

5.18

2.4

2.2

g/l

4.1

3.8

1.06

199

1468

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

2022

1.35

5.16

2.4

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

2022

1.35

5.16

2.5

2.2

g/l

7.1

7.3

1.22

203

1539

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

509

1.70

5.15

1.9

2.6

e9/l

0.2

3.26

431

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

252

1871

1.36

5.10

2.5

2.2

g/l

10.9

10.2

1.33

217

1605

(3039000) Anion gap in Blood

186

1313

1.43

5.08

6.8

7.9

mmol/l

11.5

11.3

0.41

170

1177

(3037692) Legionella sp identified in Specimen by Organism specific culture

197

2.14

5.08

1.4

—

(3018572) Chloride [Moles/volume] in Blood

186

1314

1.42

5.06

6.8

7.9

mmol/l

105.2

0.01

170

1178

(3004119) Hemoglobin [Mass/volume] in Venous blood

438

3513

1.26

5.02

4.3

3.5

g/l

130.6

131.4

0.25

418

3434

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

2.28

4.94

1.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.48

4.88

1.3

3.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2012

18384

1.12

4.84

2.2

u/l

220.4

222.5

0.02

1916

17397

(40761535) Cells panel - Urine sediment

585

4863

1.22

4.84

3.5

3.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

441

3559

1.25

4.81

1.5

—

(3024932) HLA-DR beta [Type]

263

1.94

4.80

1.0

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

462

3754

1.24

4.75

10.2

10.1

94.8

94.0

3.95

455

3743

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

301

2320

1.31

4.75

1.5

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

318

2471

1.30

4.72

4.7

4.0

47.0

50.5

1.74

312

2439

(21494815) CD4 cells/100 lymphocytes in Specimen

100

631

1.59

4.71

1.8

2.4

51.3

43.1

0.89

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

485

1.68

4.69

2.0

1.8

—

(3044889) 12 lead EKG panel

4745

45407

1.10

4.66

3.4

3.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

180

1287

1.41

4.62

2.5

2.2

g/l

131.1

132.5

0.31

142

932

(3028707) Methadone [Presence] in Urine by Screen method

129

1888

0.68

4.61

1.7

3.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

181

1301

1.40

4.52

4.5

3.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1911

1.32

4.35

2.5

2.2

g/l

3.1

0.05

202

1509

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

350

0.28

4.35

3.7

2.4

nmol/l

191.7

154.8

—

297

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1289

11533

1.14

4.32

3.3

3.5

ng/l

614.2

563.0

0.10

889

8121

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

703

1.53

4.26

1.6

1.7

—

(3003694) ABO and Rh group [Type] in Blood

2222

20554

1.11

4.21

1.6

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

172

1244

1.39

4.17

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

172

1244

1.39

4.17

1.5

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

160

1143

1.41

4.17

3.4

3.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

321

1.78

4.14

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

275

2139

1.30

4.11

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

308

1.79

4.08

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

195

2.00

4.06

1.5

ug/l

10.7

8.5

1.35

195

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

104

688

1.52

4.04

2.2

32.1

32.7

0.63

104

683

(3038515) Glucose [Moles/volume] in Venous blood

148

1052

1.41

3.98

3.6

3.0

mmol/l

7.5

7.4

0.17

143

1028

(3030981) Hyaline casts [#/volume] in Urine by Automated count

383

3114

1.24

3.97

3.0

2.6

e6/l

0.4

0.2

0.63

372

3008

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

451

3732

1.22

3.95

10.4

10.0

0.7

0.18

446

3708

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

459

5504

0.82

3.92

1.3

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

458

1.62

3.84

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1555

14174

1.12

3.83

3.9

3.6

kg/l

1.0

0.30

208

2035

(3033705) Calcium.ionized [Moles/volume] in Venous blood

601

1.54

3.80

2.7

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

129

903

1.44

3.80

1.3

1.2

—

(3004451) EKG impression Narrative

264

1.82

3.80

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

224

1717

1.31

3.76

2.7

2.3

g/l

1.1

0.8

0.39

198

1515

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

161

1174

1.38

3.76

1.3

u/ml

4.5

4.3

0.08

521

(3022313) Gas panel - Capillary blood

335

2702

1.25

3.75

5.7

3.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

198

1492

1.33

3.75

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

155

1125

1.38

3.72

3.6

2.9

mmol/l

1.6

0.01

150

1095

(3041354) Potassium [Moles/volume] in Venous blood

622

1.52

3.68

2.7

2.2

mmol/l

4.0

0.43

612

(3035285) Chloride [Moles/volume] in Venous blood

622

1.52

3.68

2.7

2.2

mmol/l

106.4

105.4

1.20

612

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.63

3.65

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

197

1491

1.33

3.63

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

240

1867

1.29

3.63

1.6

1.8

—

(3000330) Specific gravity of Urine by Test strip

344

2795

1.24

3.62

3.7

3.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

135

965

1.41

3.56

2.6

2.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

396

3274

1.22

3.54

1.7

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

447

3741

1.21

3.53

10.2

9.9

1.3

1.4

2.41

441

3717

(40765089) Chromosome analysis panel - Blood by G-banded

353

0.37

3.50

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

541

1.54

3.50

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

542

1.54

3.47

1.2

1.1

—

(4268621)

118

829

1.43

3.45

2.4

2.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

186

1408

1.33

3.44

2.6

2.2

g/l

0.0

0.00

175

1321

(3023419) Bacteria identified in Sputum by Culture

103

706

1.46

3.43

3.2

2.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1427

1.32

3.42

2.6

2.2

g/l

0.0

0.50

177

1323

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

546

1.53

3.37

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

546

1.53

3.37

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

203

1561

1.31

3.37

2.5

2.1

g/l

37.9

38.0

0.08

182

1376

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

253

1.78

3.35

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

547

1.52

3.35

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

444

1.58

3.34

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

162

1208

1.35

3.33

1.3

u/ml

5.9

3.2

1.06

396

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

541

1.52

3.29

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

517

1.53

3.29

1.2

1.1

nmol/l

387.9

384.0

0.06

468

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

200

1541

1.31

3.28

2.6

2.2

g/l

0.0

0.35

189

1434

(3042631) Mycobacterium sp identified in Specimen

104

721

1.45

3.28

3.4

2.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

330

1.67

3.27

2.1

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

361

1.64

3.26

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

369

1.63

3.25

2.0

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

239

3006

0.79

3.25

1.6

1.7

mg/l

3.2

3.8

0.83

169

2073

(3045414) Leukocytes [Presence] in Urine

343

2823

1.22

3.23

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

717

8148

0.87

3.23

1.5

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

324

2656

1.23

3.18

4.0

3.2

0.7

0.39

311

2546

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

310

1.68

3.18

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

254

2027

1.26

3.18

3.2

4.2

mmol/l

1.3

1.4

0.22

244

1997

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

237

1.78

3.12

5.1

3.9

—

(44790049)

107

754

1.42

3.11

1.6

1.5

—

(44790047)

107

754

1.42

3.11

1.6

1.5

—

(44790048)

107

754

1.42

3.11

1.6

1.5

—

(44806118)

107

754

1.42

3.11

1.6

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

117

841

1.40

3.05

1.1

96.9

0.00

112

793

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

633

1.46

3.04

1.7

1.8

—

(3003181) Sodium [Moles/volume] in Urine

126

921

1.37

2.98

1.7

1.4

mmol/l

65.6

64.6

0.08

732

(3017704) Immunofixation for Urine

286

1.68

2.96

1.8

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

531

1.49

2.95

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

114

823

1.39

2.91

6.3

7.1

mg/l

11.7

11.1

0.53

108

768

(3045683) HLA typing for celiac disease panel - Blood or Tissue

461

1.52

2.88

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

327

1.62

2.88

2.1

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

288

2360

1.23

2.87

5.7

3.9

mmol/l

24.5

24.7

0.56

267

2203

(21494890) Protein electrophoresis panel - 24 hour Urine

527

1.48

2.85

1.9

2.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.29

2.83

1.2

1.1

pmol/l

6.6

5.2

—

(4306422)

155

1182

1.32

2.80

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

441

1.52

2.78

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

106

764

1.39

2.76

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

195

1.80

2.74

1.3

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

483

1.49

2.74

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

363

1.57

2.74

1.4

1.3

u/l

233.6

399.9

1.43

333

(3043409) Potassium [Moles/volume] in Arterial blood

217

1736

1.26

2.71

3.4

4.4

mmol/l

3.8

3.9

1.50

204

1625

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

149

1136

1.32

2.71

1.1

124.9

115.3

3.54

138

1046

(4198724)

511

0.55

2.68

1.5

3.1

—

(3022621) pH of Urine by Test strip

461

3983

1.17

2.60

3.0

2.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

313

1.60

2.59

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1819

17029

1.09

2.54

3.5

3.3

mg/l

460.1

410.9

0.16

1243

11113

(3009466) Valproate [Moles/volume] in Serum or Plasma

1094

0.70

2.51

4.4

5.4

umol/l

325.6

370.2

1.88

954

(3047007) Chlamydophila sp Ab [Presence] in Serum

144

1108

1.30

2.48

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

271

1.63

2.45

1.6

2.1

—

(3022475) Manganese [Moles/volume] in Blood

2.67

2.44

1.2

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

265

1.63

2.40

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

117

1.97

2.39

1.7

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.11

2.38

1.8

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

235

1.66

2.37

1.7

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

235

1.66

2.37

1.7

2.3

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

6.25

2.37

2.4

2.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

338

1.54

2.34

2.3

1.4

u/ml

18.3

0.00

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

237

1.65

2.31

1.8

2.3

—

(3045424) Erythrocytes [Presence] in Urine

137

1059

1.30

2.31

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

242

2000

1.22

2.29

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1802

16935

1.08

2.28

1.7

1.6

mmol/l

1.4

0.61

1525

14540

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.56

2.26

1.0

1.5

umol/24h

371.2

327.2

0.24

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

208

1.69

2.25

1.7

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

384

4435

0.86

2.24

1.4

2.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1116

12093

0.91

2.23

2.8

2.7

ug/l

0.7

0.13

704

7331

(3020891) Body temperature

278

2336

1.20

2.23

4.5

5.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

100

2.00

2.20

1.5

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

529

4681

1.14

2.19

2.5

2.3

ug/l

6.7

7.8

0.81

476

4174

(3020682) Albumin/Creatinine [Ratio] in Urine

1892

17844

1.08

2.18

4.3

4.1

mg/mmol

7.8

10.0

1.56

1285

11753

(3049717) Cytology report of Urine Cyto stain

239

1986

1.21

2.16

2.3

2.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

239

0.42

2.13

1.3

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

579

1.39

2.11

1.7

2.2

73.4

73.2

0.03

556

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

537

1.40

2.11

1.8

2.2

—

(3036603) Volume of Urine

396

1.47

2.10

1.8

1.6

1725.8

2063.0

—

(3044927) Protein electrophoresis panel - Urine

488

1.42

2.08

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

300

1.54

2.07

1.5

1.3

titre

70.0

69.3

—

(3025130) Human papilloma virus identified in Specimen

128

1002

1.28

2.00

1.9

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

568

1.38

2.00

1.7

2.2

10.1

14.3

2.12

289

(40761995) Spermatozoa Progressive [#/volume] in Semen

365

0.55

2.00

4.0

3.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

303

1.52

1.99

1.7

1.5

4.2

3.6

0.12

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

364

0.55

1.98

8.1

6.3

—

(3028300) Cannabinoids [Presence] in Urine

392

4470

0.87

1.95

1.4

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

378

1.46

1.95

1.2

1.1

u/ml

9.6

17.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

478

1.40

1.95

1.1

1.2

ratio

1.0

1.23

170

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.55

1.94

1.0

u/field

1.4

1.5

—

(3027944) Amphetamines [Presence] in Urine

385

4393

0.87

1.94

1.4

2.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

290

1.52

1.91

6.6

mg/l

4701.8

754.7

0.39

206

(3027008) Opiates [Presence] in Urine

392

4462

0.87

1.91

1.4

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

677

1.33

1.90

2.5

2.1

mg/l

20.5

22.4

0.12

181

(3016879) Cocaine [Presence] in Urine

362

4139

0.87

1.88

1.4

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

149

1199

1.25

1.88

1.1

—

(40768806) Pleura Pathology biopsy report

531

0.64

1.88

1.4

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

139

1111

1.26

1.86

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.50

1.83

1.6

1.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.17

1.82

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.17

1.82

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.17

1.82

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.17

1.82

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.17

1.82

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.17

1.82

2.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

101

1.88

1.80

2.0

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

727

1.31

1.80

1.8

1.6

51.4

57.1

0.70

460

(3025018) Bordetella pertussis Ab [Titer] in Serum

419

1.41

1.79

1.2

—

(3037121) Protein [Mass/volume] in Urine

249

2122

1.18

1.77

3.3

g/l

0.3

0.28

131

976

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

359

3147

1.15

1.76

11.9

10.3

mmol/l

23.8

24.2

1.87

339

2958

(3027923) C peptide [Moles/volume] in Serum or Plasma

362

1.44

1.76

1.3

1.6

nmol/l

1.3

1.2

0.09

281

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

177

1.64

1.75

1.2

1.3

nmol/l

143.2

122.5

0.22

134

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

355

1.44

1.73

2.0

1.7

138.7

141.1

0.08

338

(3029075) Extractable nuclear Ab panel - Serum

209

1.58

1.73

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.06

1.70

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

171

1.64

1.69

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

340

1.44

1.69

1.1

1.3

nmol/l

140.9

136.1

0.32

340

(3010937) Rubella virus Ab [Presence] in Serum

2.18

1.67

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

300

3441

0.87

1.67

1.4

2.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

172

1.63

1.66

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

134

1648

0.81

1.66

1.1

u/ml

7.6

6.5

0.27

892

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

188

1.60

1.65

1.1

—

(3047189) Immunofixation for 24 hour Urine

252

1.51

1.64

1.6

1.8

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.03

1.64

2.1

2.0

umol/l

1.2

1.3

0.33

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

490

4406

1.12

1.63

3.0

2.8

ng/l

197.7

167.9

0.64

438

3942

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1574

16608

0.94

1.62

3.8

3.7

21.3

21.7

0.39

707

7100

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

404

1.39

1.58

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1147

10749

1.08

1.58

1.7

1.8

1.4

0.83

1008

9621

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6458

65477

0.94

1.58

3.7

3.6

mmol/l

1.3

0.00

6051

61334

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

191

1.57

1.56

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

223

1.53

1.56

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

569

1.32

1.55

1.8

1.5

30.9

31.9

0.09

355

(3009508) Creatinine [Moles/volume] in Urine

2048

19588

1.06

1.53

3.3

mmol/l

8.4

8.2

1.08

1767

16823

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.52

0.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.33

1.52

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

450

1.36

1.52

1.0

1.1

iu/ml

10.2

9.9

0.02

122

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

115

1.74

1.52

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

188

1589

1.19

1.51

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

241

1.50

1.51

1.6

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

425

1.37

1.51

1.4

1.5

u/l

5.6

6.4

0.73

369

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

152

1824

0.83

1.50

1.1

u/ml

2.2

1.6

0.19

773

(3039443) Prostate specific Ag panel - Serum or Plasma

125

1529

0.81

1.50

1.5

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

305

2680

1.14

1.49

1.8

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

242

1.49

2.3

2.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.07

1.49

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

452

1.35

1.48

2.5

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

194

1.55

1.47

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

558

1.31

1.45

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.50

1.45

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.50

1.45

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.92

1.43

1.1

1.4

—

(3045788) Cell count panel - Pleural fluid

473

0.68

1.43

1.3

1.5

—

(3000012) Reticulocyte production index

286

1.44

1.42

1.3

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.82

1.41

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

312

1.41

1.40

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

131

1581

0.83

1.39

1.1

u/ml

0.6

1.4

2.03

702

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

400

3598

1.12

1.37

2.2

2.4

u/l

5313.9

6109.0

0.19

140

1418

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

590

1.29

1.37

1.4

1.3

nmol/l

1.4

0.00

526

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.20

1.36

1.7

—

(3011985) Renin [Units/volume] in Plasma

108

877

1.23

1.34

1.5

mu/l

62.3

64.3

0.06

790

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1091

0.80

1.34

1.3

mmol/l

6.7

7.0

0.60

798

(3021788) Differential panel - Synovial fluid

134

1114

1.21

1.33

1.6

—

(3048879) Bone marrow aspiration report

144

1.60

1.31

1.5

2.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

113

1.68

1.31

1.3

1.1

ng/l

40.7

61.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

1.30

2.3

2.6

—

(40768446) Kidney Pathology biopsy report

326

1.38

1.29

1.9

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.35

1.29

2.5

2.6

—

(3016750) Collection duration of Urine

369

1.36

1.28

2.6

2.2

min

513.2

494.2

0.75

288

(4281824)

601

0.73

1.28

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.78

1.28

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

144

1212

1.19

1.27

1.5

1.6

—

(3000492) Spirometry study

789

7360

1.08

1.26

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

1178

1.19

1.24

1.5

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.86

1.23

1.0

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.77

1.22

1.1

1.4

83.8

54.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

530

1.29

1.22

3.7

3.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

213

2433

0.87

1.20

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

101

1.68

1.19

1.1

1.3

—

(3011288) Drugs identified in Urine by Screen method

261

2940

0.88

1.19

1.8

3.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

648

1.25

1.18

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

214

2439

0.87

1.17

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

464

0.71

1.17

1.8

1.6

—

(21494755) Public health laboratory ask at order entry panel

907

9634

0.93

1.17

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.70

1.17

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

213

2427

0.87

1.16

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

141

1196

1.18

1.16

1.2

1.1

au/ml

10.3

12.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.50

1.15

1.6

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

110

1.64

1.15

1.4

1.6

nmol/l

6.5

424725.9

1.08

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.85

1.13

1.0

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.85

1.13

1.5

1.6

mg/l

2.9

5.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.85

1.13

1.5

1.6

mg/l

6.2

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

161

1385

1.17

1.12

2.2

2.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

215

2440

0.88

1.12

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

273

3051

0.89

1.11

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

399

4369

0.91

1.10

1.2

—

(4034850)

242

2148

1.13

1.09

9.7

8.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

667

1.23

1.06

1.4

mmol/l

10.8

11.9

0.55

161

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.92

1.06

2.0

5.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

313

1.34

1.06

1.2

1.6

u/field

1.5

3.4

1.60

230

(40768795) Lymph node Pathology biopsy report

578

1.25

1.05

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

522

0.75

1.04

1.3

1.5

e6/l

13749.4

72174.0

2.53

301

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

732

1.22

1.04

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

195

1.44

1.04

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

778

1.21

1.04

1.1

—

(3012441) Differential panel - Pleural fluid

521

0.75

1.03

1.3

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.27

1.03

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

179

1.45

1.02

1.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

114

1.58

1.02

1.4

2.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

826

1.20

1.01

1.2

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.77

1.00

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.88

1.00

1.0

1.2

u/l

37.9

11.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

256

1.37

1.00

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

343

1.31

0.99

1.6

2.2

umol/l

72.7

154.4

2.68

166

(3019420) Tryptase [Mass/volume] in Serum or Plasma

405

1.29

0.98

1.2

1.5

ug/l

6.7

7.8

0.39

357

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

204

1807

1.13

0.98

1.3

1.4

mg/l

499.4

508.5

0.09

198

1716

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.80

0.98

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

180

1582

1.14

0.97

1.3

mmol/l

3.8

3.7

0.15

166

1488

(3043238) Trisomy 21 risk [Likelihood] in Fetus

180

2041

0.88

0.96

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

182

1.43

0.95

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.95

0.0

1.2

—

1.6

—

(40768800) Prostate Pathology biopsy report

1140

0.84

0.94

1.3

1.2

—

(3019977) pH of Arterial blood

311

1.32

0.94

2.3

3.0

7.4

0.32

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

225

2012

1.12

0.94

1.9

pmol/l

208.6

202.0

0.38

217

1914

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

145

0.55

0.92

2.3

2.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.82

0.92

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.14

0.91

1.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

171

0.58

0.91

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

237

2131

1.12

0.91

2.2

2.4

ug/l

264.8

502.5

2.49

215

1997

(3005033) Fetal Nuchal fold Thickness US

175

1978

0.88

0.90

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

653

0.80

0.89

1.3

1.5

g/l

33.8

0.00

589

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

447

1.25

0.89

1.5

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.91

0.88

1.3

1.7

umol/l

36.8

45.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

350

1.29

0.88

1.1

95.2

95.9

0.07

291

(3016038) Potassium [Moles/volume] in Urine

368

1.28

0.88

1.6

1.2

mmol/l

30.4

36.1

1.18

325

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

237

2625

0.90

0.87

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6844

69002

0.96

0.87

4.4

4.3

mmol/l

2.8

7.12

6414

64751

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.61

0.87

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.86

0.87

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

108

924

1.17

0.87

1.4

1.7

—

(3003129) Base excess in Capillary blood by calculation

136

1.47

0.86

1.9

1.7

mmol/l

-1.8

0.7

1.05

126

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

108

925

1.17

0.86

1.2

1.3

nmol/l

0.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.82

0.85

1.0

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

161

1423

1.13

0.84

1.6

e6/l

9144.8

14085.9

1.69

120

1022

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

535

0.78

0.83

1.7

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

677

6398

1.06

0.82

2.2

nmol/l

13.3

13.2

0.22

620

5753

(3047352) Trisomy 18 risk [Likelihood] in Fetus

177

1983

0.89

0.81

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

653

1.20

0.81

6.5

16.2

mmol/l

7.1

7.3

0.19

544

(3006576) Bicarbonate [Moles/volume] in Blood

223

1.35

0.81

5.7

6.4

mmol/l

24.4

24.6

0.11

210

(4010399)

478

4467

1.07

0.81

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

355

1.27

0.81

1.5

—

(4024509)

526

1.22

0.81

1.7

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

155

1.42

0.80

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.70

0.80

1.3

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

181

1.38

0.79

2.2

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

181

1.38

0.79

2.2

3.1

—

(3004775) Volume in Urine collected for unspecified duration

482

1.23

0.79

2.5

2.3

807.5

643.5

1.40

346

(3027456) Digoxin [Moles/volume] in Serum or Plasma

739

1.18

0.78

3.1

3.0

nmol/l

0.8

0.06

552

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

479

5110

0.93

0.77

1.2

iu/ml

89.6

152.0

5.49

178

1941

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

130

1141

1.14

0.77

1.1

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

140

1.43

0.76

2.9

4.2

u/l

83.3

95.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

412

1.24

0.76

1.1

nmol/l

0.7

5.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.77

0.76

1.3

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.77

0.76

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

185

0.65

0.75

1.8

2.2

umol/l

14.6

15.6

0.13

185

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

290

0.72

0.74

2.0

ug/min

10.7

196.8

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.08

0.74

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6727

67787

0.96

0.74

4.0

mmol/l

1.4

1.95

6334

63758

(3023199) Leukocytes [#/volume] in Pleural fluid

591

0.81

0.73

1.3

1.5

e6/l

2452.9

2678.2

0.15

418

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

308

2844

1.09

0.73

1.3

miu/ml

232.7

223.5

0.15

132

1321

(3024928) Oxygen saturation in Venous blood

148

1316

1.13

0.73

4.8

3.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1077

0.86

0.73

1.0

1.1

u/ml

0.4

0.6

0.14

247

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

263

1.29

0.72

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.80

0.72

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

134

1.42

0.71

1.1

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

435

1.22

0.70

1.9

2.7

35.3

41.4

0.71

150

(4211845)

309

1.26

0.70

2.4

2.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

160

1.38

0.70

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

160

1.38

0.70

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

160

1.38

0.70

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

137

1538

0.89

0.69

1.1

u/ml

1.9

2.3

0.12

392

(4015189)

135

1.41

0.68

1.7

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

834

1.15

0.68

1.4

pmol/l

331.0

328.3

0.02

640

(3002619) Bacteria identified in Specimen by Culture

127

1.42

0.67

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

392

1.23

0.67

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.49

0.66

1.9

—

(3014271) Vancomycin [Susceptibility]

223

1.30

0.66

2.4

2.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6456

65058

0.97

0.65

4.0

mmol/l

5.8

0.17

5989

60378

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

163

1.35

0.64

1.2

1.1

76.3

78.4

—

(3022689) Creatine [Moles/volume] in Urine

201

0.70

0.64

2.9

1.5

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.72

0.64

1.6

1.9

—

0.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

425

3999

1.07

0.64

1.3

1.4

iu/l

28.7

25.4

1.16

371

3413

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

496

1.19

0.63

2.5

3.0

—

25.3

—

(3030313) Adrenal Ab [Titer] in Serum

1.55

0.62

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.59

0.61

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

312

2910

1.07

0.61

2.4

2.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.60

0.61

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1115

10772

1.04

0.61

2.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

156

1.35

0.60

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

156

1.35

0.60

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

156

1.35

0.60

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

156

1.35

0.60

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

407

1.21

0.60

1.6

1.9

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.60

0.0

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

2.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.59

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

399

1.20

0.59

5.1

6.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

382

1.21

0.57

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.71

0.57

1.0

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.56

1.3

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

207

0.72

0.56

2.1

1.8

—

(40757373) Influenza virus identified in Isolate

116

1.38

0.54

1.3

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

108

1206

0.89

0.54

1.1

u/ml

6.8

4.6

0.42

506

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

294

1.23

0.54

1.6

1.9

—

(3051593) INR in Capillary blood by Coagulation assay

213

1.27

0.53

3.7

9.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

240

1.25

0.53

1.2

102.9

89.3

1.29

116

(21494434) Karyotype in Bone marrow

488

1.17

0.52

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

143

1.33

0.52

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

250

1.24

0.52

1.2

115.8

105.9

0.79

228

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

241

1.25

0.52

2.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.62

0.52

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

527

1.16

0.51

1.0

1.1

u/ml

5.3

2.7

0.28

145

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

696

1.14

0.50

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

251

1.24

0.50

1.2

1.1

100.7

90.4

2.50

120

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.47

0.50

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

401

0.82

0.50

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

628

6537

0.96

0.48

2.1

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

118

1301

0.91

0.48

1.1

u/ml

2.5

3.8

0.89

531

(3024869) Neuronal Ab [Presence] in Serum

108

0.65

0.48

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

926

9559

0.96

0.47

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

102

1.37

0.47

13.4

7.7

60.7

70.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

111

1225

0.90

0.47

1.2

1.3

ug/l

2.4

4.0

3.59

101

1120

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

114

1034

1.10

0.46

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

173

1.27

0.46

1.0

1.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.38

0.45

1.3

1.4

—

97.6

—

(3017509) Phencyclidine [Presence] in Urine

117

0.68

0.45

1.1

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

883

1.11

0.45

1.8

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

162

1497

1.08

0.45

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

515

1.15

0.45

1.4

2.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.40

0.45

1.0

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

165

1.27

0.44

1.2

76.8

67.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

1.28

0.43

12.1

5.0

—

(3020650) Glucose [Presence] in Urine

202

1.24

0.43

1.3

1.4

—

(3044007) Cell count panel - Peritoneal fluid

174

0.75

0.43

1.8

2.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

229

0.79

0.42

2.1

2.9

umol/l

28.2

28.7

0.08

167

(3023511) Choriogonadotropin [Units/volume] in Urine

194

1812

1.07

0.42

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

114

1246

0.91

0.41

1.3

1.4

u/l

25.7

23.7

0.28

1031

(3045142) Bone marrow Pathology biopsy report

632

1.12

0.41

1.2

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

499

0.86

0.41

2.5

3.5

mu/l

40.1

29.7

0.57

472

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.41

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

249

1.21

0.41

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.52

0.41

5.0

2.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

150

0.73

0.41

1.0

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

240

1.21

0.41

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

351

1.17

0.41

1.0

ng/l

345.4

314.3

0.25

258

(3010144) Erythrocytes [#/volume] in Synovial fluid

539

1.13

0.40

1.3

1.4

e6/l

252974.5

70590.9

0.62

375

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.40

0.0

1.2

—

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.40

0.0

1.3

—

18.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

172

1604

1.07

0.40

1.4

e6/l

82.9

21.7

0.45

134

1236

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

172

1604

1.07

0.40

1.4

1.5

e6/l

691.9

3339.2

0.60

143

1310

(3001019) Free T4 and TSH panel - Serum or Plasma

443

4618

0.96

0.39

1.5

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.34

0.39

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.43

0.39

5.0

2.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

6.6

—

0.3

—

(3020491) Glucose [Moles/volume] in Blood

513

1.13

0.38

1.6

1.8

mmol/l

7.0

6.3

0.93

371

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

270

1.19

0.38

1.1

1.2

g/l

0.3

0.93

215

(1761868) Lipid panel - Serum or Plasma

2713

27499

0.98

0.38

2.6

2.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.32

0.37

1.6

1.3

—

(3006462) Nitrate [Presence] in Urine

280

1.18

0.37

2.5

2.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.33

0.37

2.9

1.6

ng/l

126.8

134.5

0.07

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.35

0.37

1.2

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

115

0.70

0.37

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

152

1.25

0.37

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6069

61034

0.98

0.36

5.3

5.0

mmol/mol

38.9

39.0

0.41

5713

57387

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

134

1.27

0.36

1.1

—

(4133840)

235

0.81

0.36

1.4

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.27

0.36

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

318

3330

0.95

0.36

1.5

1.7

mu/l

281.3

293.6

0.33

289

3013

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.33

0.35

2.3

pmol/l

53.3

77.9

0.74

(3000285) Sodium [Moles/volume] in Blood

0.66

0.35

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

526

1.12

0.35

1.2

1.3

u/ml

0.5

1.0

0.45

209

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

157

0.76

0.35

1.1

u/ml

0.1

5.3

—

117

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.40

0.35

6.0

6.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

303

2893

1.05

0.34

1.7

1.8

nmol/l

38.9

39.1

0.04

298

2820

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

405

0.86

0.34

1.3

1.4

mmol/l

5.3

5.6

1.36

383

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

509

4916

1.04

0.34

2.3

au/ml

25.7

21.5

0.32

333

(3041806) Other cells [#/volume] in Blood by Manual count

386

1.14

0.34

1.6

1.5

—

(40765096) Chromosome analysis panel by Banding

172

1.22

0.34

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

283

1.17

0.34

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

1375

1.07

0.33

1.8

2.4

nmol/l

1.0

0.8

1.12

127

1161

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

552

0.89

0.33

1.1

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

127

1.26

0.33

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

133

0.75

0.33

2.3

2.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.68

0.33

1.2

3.4

umol/l

27.8

43.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

350

1.14

0.32

1.0

ng/l

765.3

764.6

0.00

250

(3034426) Prothrombin time (PT)

294

1.16

0.32

1.4

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.28

0.32

1.3

1.2

—

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

122

1136

1.08

0.32

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

444

0.88

0.32

1.4

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

128

1.25

0.31

1.1

1.8

ug/l

1.2

2.0

1.73

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

665

1.10

0.31

1.0

1.1

mg/l

220.7

258.2

1.97

590

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

276

1.16

0.31

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

276

1.16

0.31

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2059

20884

0.98

0.31

4.3

ug/l

2.1

2.5

1.00

1861

18961

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

779

0.91

0.31

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

124

1328

0.93

0.31

1.4

1.5

nmol/l

0.4

0.03

100

1059

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.72

0.30

1.0

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

352

1.14

0.30

1.0

ng/l

40.3

43.8

0.21

253

(3044941) Cell count panel - Synovial fluid

103

955

1.08

0.30

1.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

196

0.82

0.29

1.7

2.0

e6/l

9933.7

13632.4

0.13

112

(4027681)

534

1.11

0.29

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1209

11866

1.02

0.29

2.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.23

0.29

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

1.20

0.28

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.29

0.28

1.4

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

565

1.10

0.28

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

280

0.86

0.28

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

700

0.91

0.27

1.5

1.6

mmol/l

7.2

7.7

0.90

431

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.23

0.27

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.28

0.26

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.70

0.26

1.4

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

155

1471

1.05

0.25

2.7

2.5

ug/min

82.1

124.1

0.78

954

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

622

0.92

0.24

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

686

1.08

0.24

1.1

mg/l

41.6

40.4

0.08

574

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

571

1.09

0.23

2.2

2.7

—

(3001556) Androgen free Index in Serum or Plasma

115

1.22

0.23

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

380

0.89

0.23

5.7

6.8

u/ml

32.8

7518.7

—

(3000060) B lymphocytes [#/volume] in Blood

237

1.14

0.23

1.8

2.2

e6/l

275.3

169.8

0.55

124

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.28

0.23

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

247

1.13

0.22

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.25

0.22

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

796

1.07

0.22

1.4

—

(3024263) Appearance of Synovial fluid

333

1.11

0.22

1.4

1.8

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

172.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

689

0.93

0.21

1.5

promille

1.1

1.4

0.87

516

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

156

0.83

0.21

1.2

1.3

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

5.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

145

1.17

0.20

1.2

pmol/l

238.7

281.9

0.29

105

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

335

1.10

0.20

2.1

2.5

ug/l

25.4

170.9

0.95

312

(3012494) Peanut IgE Ab [Units/volume] in Serum

240

0.87

0.20

1.0

1.1

u/ml

0.3

2.6

—

134

(44806420)

123

0.81

0.20

2.4

2.3

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

10263.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

666

0.93

0.20

1.9

2.2

nmol/l

21.4

19.9

0.59

634

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

745

7317

1.02

0.19

7.4

6.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

250

1.12

0.19

1.2

g/l

—

0.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

146

1.16

0.19

1.4

1.2

g/l

37.4

38.3

0.11

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

405

1.09

0.18

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

745

0.94

0.18

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

178

1715

1.04

0.18

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

453

4631

0.98

0.18

1.5

—

(3033799) Differential panel - Peritoneal fluid

185

0.86

0.18

2.1

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

463

4532

1.02

0.17

1.3

au/ml

56.3

48.7

0.26

191

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.15

0.17

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

120

1254

0.96

0.17

2.2

titre

14.8

8.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6802

68180

0.99

0.17

4.1

4.0

mmol/l

4.7

5.70

6438

64371

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

1.19

0.16

1.0

1.1

u/ml

0.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

294

3017

0.97

0.16

2.1

3.1

u/ml

43.1

44.5

0.03

284

2909

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.16

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.16

0.16

1.9

—

(1002224) Polysomnography panel

351

3593

0.98

0.16

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

277

0.90

0.16

2.5

2.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

154

1485

1.04

0.16

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

119

0.84

0.15

7.2

7.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.15

0.15

2.1

2.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

140

0.86

0.15

1.7

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.15

1.2

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

156

1508

1.04

0.15

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

246

1.10

0.14

3.7

2.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

131

1.15

0.14

1.9

2.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

307

3139

0.98

0.14

2.0

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

151

1.13

0.13

1.4

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

810

8197

0.99

0.13

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

335

1.07

0.13

2.4

2.7

umol/l

12.2

21.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

148

0.88

0.12

5.8

7.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

529

0.94

0.12

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

205

2001

1.03

0.12

1.9

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

507

0.95

0.11

1.0

u/ml

0.2

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

799

1.04

0.11

1.3

1.4

pmol/l

83.7

107.4

0.24

236

(44806071)

115

0.87

0.10

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

115

0.87

0.10

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

102

987

1.03

0.10

1.2

1.3

u/l

30.5

35.9

0.26

857

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

454

0.95

0.10

1.1

u/l

1.0

1.1

0.11

205

(4146454)

574

1.05

0.10

2.5

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

437

1.05

0.10

2.1

1.9

u/field

1.5

1.9

0.46

191

(3035880) pH of Pleural fluid

269

0.93

0.10

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.11

0.09

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.06

0.09

1.4

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

243

2386

1.02

0.09

1.7

1.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

116

1.12

0.09

2.8

3.2

u/l

754.8

1929.0

0.76

106

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

106

1091

0.97

0.09

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.11

0.09

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.07

0.08

1.0

1.3

mmol/l

7.9

5.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.05

0.08

2.2

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

512

5176

0.99

0.08

1.9

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.03

0.08

1.3

1.4

75.6

71.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

128

1311

0.98

0.08

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

224

2202

1.02

0.08

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.14

0.08

10.3

10.8

mmol/l

5.1

6.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.14

0.08

3.4

3.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.04

0.08

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.03

0.07

1.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

638

1.03

0.07

1.1

—

(3014891) Appearance of Pleural fluid

0.83

0.07

2.0

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

723

7288

0.99

0.07

4.0

32.2

31.5

0.96

556

5220

(3043410) Blood group antigens tested for on Red Blood Cells

176

1.08

0.07

2.2

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

659

1.03

0.07

3.9

4.7

u/ml

55.3

68.8

0.19

200

(4038314)

0.88

0.06

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.11

0.06

6.0

7.4

—

(44813793)

523

1.03

0.06

1.0

1.1

—

(40768793) Breast Pathology biopsy report

122

1243

0.98

0.06

1.4

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

439

4354

1.01

0.05

3.5

3.4

pmol/l

4.5

0.14

395

3903

(3005570) Glucose [Moles/volume] in Urine

607

0.97

0.05

1.7

1.8

—

0.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

132

1342

0.98

0.05

3.8

3.2

mg/l

21.7

26.7

1.28

823

(3045716) Anion gap in Serum or Plasma

262

0.95

0.04

3.6

2.5

mmol/l

9.2

0.01

196

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

246

2485

0.99

0.04

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

119

0.92

0.03

1.0

1.3

mg/l

0.3

115.0

—

(4094501)

178

1762

1.01

0.03

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

290

1.03

0.03

1.2

1.1

ng/l

142.8

329.7

0.63

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

122

1207

1.01

0.02

1.1

iu/ml

25.6

9026.3

0.64

299

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

148

0.95

0.02

1.0

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

162

1.05

0.02

6.5

6.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

109

1079

1.01

0.02

1.2

1.6

—

(3017569) Oxygen content in Arterial blood

248

0.97

0.02

2.4

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

571

1.02

0.02

3.4

3.1

mg/l

58.3

67.5

0.11

427

(3009214) Lutropin [Units/volume] in Serum or Plasma

275

2760

1.00

0.01

1.4

u/l

9.1

8.6

0.24

226

2256

(3026470) Cobalt [Mass/volume] in Blood

307

0.98

0.01

2.0

ug/l

2.2

3.3

1.37

270

(3014599) Egg white IgE Ab [Units/volume] in Serum

547

0.99

0.01

1.0

1.1

u/ml

0.9

3.0

1.09

129

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

123

0.98

0.00

1.2

ug/l

18.5

213.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

193

0.98

0.00

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.05

0.00

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

135

1.04

0.00

1.3

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

155

1.03

0.00

1.0

1.1

—

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

171

1705

1.00

0.00

1.9

iu/l

3.4

4.4

1.18

646

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

862

1.00

0.00

1.1

—

14.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

331

1.00

0.00

1.6

nmol/l

4.4

12.1

0.49

263

(3008295) Osmolality of Serum or Plasma

619

1.00

0.00

1.3

1.5

mosm/kgh2o

280.7

281.0

0.03

484

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

38.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

160

1.00

0.00

1.4

2.7

ng/l

96.0

123.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.00

0.00

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

110

1.00

0.00

1.8

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.02

0.00

1.0

1.5

pmol/l

5.1

15.4

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.02

0.00

1.2

mg/l

6.8

10.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.97

0.00

1.3

u/l

25.7

478.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.94

0.00

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3019174) dRVVT (LA screen)

1.00

0.00

1.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_KELAUC – UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51) (K11_KELAUC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints